KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) FCF Margin (2016 - 2025)

Biogen (BIIB) has 17 years of FCF Margin data on record, last reported at 20.53% in Q4 2025.

  • For Q4 2025, FCF Margin fell 886.0% year-over-year to 20.53%; the TTM value through Dec 2025 reached 20.73%, down 739.0%, while the annual FY2025 figure was 20.73%, 739.0% down from the prior year.
  • FCF Margin reached 20.53% in Q4 2025 per BIIB's latest filing, down from 48.38% in the prior quarter.
  • Across five years, FCF Margin topped out at 48.38% in Q3 2025 and bottomed at 10.28% in Q4 2022.
  • Average FCF Margin over 5 years is 22.18%, with a median of 24.01% recorded in 2022.
  • Peak YoY movement for FCF Margin: surged 4466bps in 2021, then plummeted -3905bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 28.78% in 2021, then tumbled by -136bps to 10.28% in 2022, then skyrocketed by 299bps to 20.48% in 2023, then surged by 44bps to 29.4% in 2024, then crashed by -30bps to 20.53% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 20.53% in Q4 2025, 48.38% in Q3 2025, and 5.08% in Q2 2025.